Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Drug use evaluation of liraglutide in type 2 diabetes mellitus patients

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: HUANG, Yun-Ting (Taipei, China Taiwan)
  • Co-author(s): Tsai, Tzu-Cheng (, Taipei, China Taiwan)
    Chen, Wei-Li (, Taipei, China Taiwan)
    Deng, Shin-Tarng (, Taipei, China Taiwan)
  • Abstract:

    1. Background
    Diabetes mellitus (DM) and its complications have been major cause of death in theworld. A new glucagon-like peptide 1 (GLP-1) analog, liraglutide, was availablein medical hospital in April 2013. Liraglutide and exenatide are both GLP-1analogs, however, patients often withdraw exenatide due to adverse effects.
    2. Aims
    To investigate..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses